A detailed history of Menard Financial Group LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Menard Financial Group LLC holds 1,696 shares of JNJ stock, worth $273,344. This represents 0.18% of its overall portfolio holdings.

Number of Shares
1,696
Previous 1,696 -0.0%
Holding current value
$273,344
Previous $268,000 7.84%
% of portfolio
0.18%
Previous 0.24%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$155.22 - $162.74 $14,280 - $14,972
-92 Reduced 5.15%
1,696 $268,000
Q3 2023

Nov 14, 2023

SELL
$155.75 - $174.48 $337,666 - $378,272
-2,168 Reduced 54.8%
1,788 $278,000
Q2 2023

Aug 14, 2023

SELL
$154.35 - $166.11 $49,392 - $53,155
-320 Reduced 7.48%
3,956 $654,000
Q1 2023

May 12, 2023

BUY
$151.05 - $180.26 $126,428 - $150,877
837 Added 24.34%
4,276 $662,000
Q3 2022

Nov 14, 2022

SELL
$161.33 - $179.52 $3,871 - $4,308
-24 Reduced 0.69%
3,439 $562,000
Q1 2022

Apr 25, 2022

SELL
$158.14 - $179.59 $91,088 - $103,443
-576 Reduced 14.26%
3,463 $614,000
Q4 2021

Feb 14, 2022

SELL
$155.93 - $173.01 $111,489 - $123,702
-715 Reduced 15.04%
4,039 $691,000
Q3 2021

Nov 15, 2021

SELL
$161.5 - $179.47 $646 - $717
-4 Reduced 0.08%
4,754 $768,000
Q2 2021

Aug 11, 2021

BUY
$159.48 - $171.07 $13,236 - $14,198
83 Added 1.78%
4,758 $784,000
Q1 2021

May 17, 2021

BUY
$153.07 - $170.48 $11,480 - $12,786
75 Added 1.63%
4,675 $768,000
Q4 2020

Feb 09, 2021

BUY
$137.11 - $157.38 $9,734 - $11,173
71 Added 1.57%
4,600 $724,000
Q3 2020

Nov 12, 2020

SELL
$140.38 - $153.83 $28,356 - $31,073
-202 Reduced 4.27%
4,529 $674,000
Q2 2020

Aug 13, 2020

BUY
$128.81 - $155.51 $609,400 - $735,717
4,731 New
4,731 $665,000
Q1 2020

May 15, 2020

SELL
$111.14 - $153.99 $1.03 Million - $1.43 Million
-9,276 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$127.5 - $146.44 $1.18 Million - $1.36 Million
9,276 New
9,276 $1.35 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $421B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Menard Financial Group LLC Portfolio

Follow Menard Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Menard Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Menard Financial Group LLC with notifications on news.